TY - JOUR
T1 - Adhesive Composite Hydrogel Patch for Sustained Transdermal Drug Delivery To Treat Atopic Dermatitis
AU - Kim, Ye Eun
AU - Jung, Hoo Yeon
AU - Park, Nuri
AU - Kim, Jaeyun
N1 - Publisher Copyright:
© 2023 American Chemical Society.
PY - 2023/2/14
Y1 - 2023/2/14
N2 - Atopic dermatitis (AD) is a common chronic inflammatory skin disease. Continuous administration of steroids often causes undesired side effects; hence, drug delivery systems with high loading capacities and sustained release profiles are required. Herein, adhesive hydrogels for sustained transdermal delivery of dexamethasone (DEX), a potent corticosteroid, have been suggested for AD treatment. The adhesive composite hydrogels comprise a double network of polyacrylamide (PAM) and polydopamine (PDA) embedded with extra-large-pore mesoporous silica nanoparticles (XL-MSNs). The intrinsic skin adhesiveness of the dopamine-derived PAM/PDA hydrogels is further enhanced by XL-MSN incorporation that contributes to the simultaneous enhancement of cohesion and adhesion of the hydrogel. The resulting adhesive hydrogels exhibit a high water content and strong adhesion to porcine skin. A sustained release of DEX is obtained when DEX is loaded within the pores of XL-MSNs in PAM/PDA hydrogels compared to the rapid release from the direct loading of DEX in hydrogels. Application of DEX-loaded MSN@PAM/PDA hydrogels on an AD mouse model led to the significant suppression of AD symptoms, including the restoration of the thickened epidermal layer, decrease in inflammatory cell infiltration in the skin, recovery of collagen deposition, and decreased levels of immunoglobulin E. XL-MSN-embedded adhesive hydrogels could be a potential platform for topical drug delivery to treat inflammatory skin diseases.
AB - Atopic dermatitis (AD) is a common chronic inflammatory skin disease. Continuous administration of steroids often causes undesired side effects; hence, drug delivery systems with high loading capacities and sustained release profiles are required. Herein, adhesive hydrogels for sustained transdermal delivery of dexamethasone (DEX), a potent corticosteroid, have been suggested for AD treatment. The adhesive composite hydrogels comprise a double network of polyacrylamide (PAM) and polydopamine (PDA) embedded with extra-large-pore mesoporous silica nanoparticles (XL-MSNs). The intrinsic skin adhesiveness of the dopamine-derived PAM/PDA hydrogels is further enhanced by XL-MSN incorporation that contributes to the simultaneous enhancement of cohesion and adhesion of the hydrogel. The resulting adhesive hydrogels exhibit a high water content and strong adhesion to porcine skin. A sustained release of DEX is obtained when DEX is loaded within the pores of XL-MSNs in PAM/PDA hydrogels compared to the rapid release from the direct loading of DEX in hydrogels. Application of DEX-loaded MSN@PAM/PDA hydrogels on an AD mouse model led to the significant suppression of AD symptoms, including the restoration of the thickened epidermal layer, decrease in inflammatory cell infiltration in the skin, recovery of collagen deposition, and decreased levels of immunoglobulin E. XL-MSN-embedded adhesive hydrogels could be a potential platform for topical drug delivery to treat inflammatory skin diseases.
UR - https://www.scopus.com/pages/publications/85147202762
U2 - 10.1021/acs.chemmater.2c03234
DO - 10.1021/acs.chemmater.2c03234
M3 - Article
AN - SCOPUS:85147202762
SN - 0897-4756
VL - 35
SP - 1209
EP - 1217
JO - Chemistry of Materials
JF - Chemistry of Materials
IS - 3
ER -